Theodore E Hebert
Examiner (ID: 6600, Phone: (571)270-1409 , Office: P/2199 )
Most Active Art Unit | 2199 |
Art Unit(s) | 2198, 2199 |
Total Applications | 481 |
Issued Applications | 338 |
Pending Applications | 58 |
Abandoned Applications | 84 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17342230
[patent_doc_number] => 20220008561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => BISMUTH METAL-ORGANIC FRAMEWORKS FOR USE AS X-RAY COMPUTED TOMOGRAPHY CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/293176
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293176 | BISMUTH METAL-ORGANIC FRAMEWORKS FOR USE AS X-RAY COMPUTED TOMOGRAPHY CONTRAST AGENTS | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17235506
[patent_doc_number] => 11179369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Sustained release pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/672296
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11184
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16672296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/672296 | Sustained release pharmaceutical compositions | Oct 31, 2019 | Issued |
Array
(
[id] => 15863167
[patent_doc_number] => 20200138987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => COMPOSITION FOR MATERIAL DELIVERY, INCLUDING EXOSOME MIMETICS DERIVED FROM RED BLOOD CELLS, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/670044
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670044 | Composition for material delivery, including exosome mimetics derived from red blood cells, and use thereof | Oct 30, 2019 | Issued |
Array
(
[id] => 15524933
[patent_doc_number] => 20200054772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Nanoparticle Photoacoustic Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/661067
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661067 | Nanoparticle Photoacoustic Imaging Agents | Oct 22, 2019 | Abandoned |
Array
(
[id] => 15797335
[patent_doc_number] => 20200121810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => High-Intensity Focused Ultrasound-Induced Mechanochemical Transduction in Synthetic Elastomers
[patent_app_type] => utility
[patent_app_number] => 16/654569
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16654569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/654569 | High-Intensity Focused Ultrasound-Induced Mechanochemical Transduction in Synthetic Elastomers | Oct 15, 2019 | Pending |
Array
(
[id] => 17821548
[patent_doc_number] => 11426472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
[patent_app_type] => utility
[patent_app_number] => 17/285717
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 6464
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285717 | Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis | Oct 14, 2019 | Issued |
Array
(
[id] => 15765991
[patent_doc_number] => 20200114013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Boron Enriched Linker ("BEL") compositions for boron neutron capture therapy and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/602468
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16602468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/602468 | Boron enriched linker ("BEL") compositions for boron neutron capture therapy and methods thereof | Oct 9, 2019 | Issued |
Array
(
[id] => 17398248
[patent_doc_number] => 20220040338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => Alpha Emitter Compositions And Methods
[patent_app_type] => utility
[patent_app_number] => 17/275978
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275978 | Alpha Emitter Compositions And Methods | Sep 12, 2019 | Pending |
Array
(
[id] => 15708821
[patent_doc_number] => 20200101176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Small Highly Uniform Nanomedicine Compositions for Therapeutic, Imaging and Theranostic Applications
[patent_app_type] => utility
[patent_app_number] => 16/570784
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570784 | Small Highly Uniform Nanomedicine Compositions for Therapeutic, Imaging and Theranostic Applications | Sep 12, 2019 | Abandoned |
Array
(
[id] => 16917667
[patent_doc_number] => 20210190759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITION FOR DETECTING HYDROGEN SULFIDE OR MEASURING HYDROGEN SULFIDE CONCENTRATION AND COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR DIAGNOSING OR IMAGING IN VIVO INFLAMMATION, TISSUES HAVING HYPOXIC DAMAGE, OR CANCER
[patent_app_type] => utility
[patent_app_number] => 17/272636
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272636
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272636 | COMPOSITION FOR DETECTING HYDROGEN SULFIDE OR MEASURING HYDROGEN SULFIDE CONCENTRATION AND COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR DIAGNOSING OR IMAGING IN VIVO INFLAMMATION, TISSUES HAVING HYPOXIC DAMAGE, OR CANCER | Sep 10, 2019 | Pending |
Array
(
[id] => 18152038
[patent_doc_number] => 11564988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Single wall nanotube constructs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/564322
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 41
[patent_no_of_words] => 25868
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16564322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/564322 | Single wall nanotube constructs and uses thereof | Sep 8, 2019 | Issued |
Array
(
[id] => 16799342
[patent_doc_number] => 10994259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Metal-organic frameworks for the adsorption and catalytic transformations of carbon dioxide
[patent_app_type] => utility
[patent_app_number] => 16/545815
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 4619
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16545815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/545815 | Metal-organic frameworks for the adsorption and catalytic transformations of carbon dioxide | Aug 19, 2019 | Issued |
Array
(
[id] => 16868611
[patent_doc_number] => 20210162078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHOD FOR DIAGNOSIS OF DOPAMINERGIC AND MOVEMENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/265850
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265850 | METHOD FOR DIAGNOSIS OF DOPAMINERGIC AND MOVEMENT DISORDERS | Aug 6, 2019 | Abandoned |
Array
(
[id] => 15493343
[patent_doc_number] => 20200046860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Systems and Methods for the Detection of Hydroxychloroquine-Mediated Cardiotoxicity
[patent_app_type] => utility
[patent_app_number] => 16/533114
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16533114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/533114 | Systems and Methods for the Detection of Hydroxychloroquine-Mediated Cardiotoxicity | Aug 5, 2019 | Abandoned |
Array
(
[id] => 15145201
[patent_doc_number] => 20190351078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Ultrasound Gel Composition
[patent_app_type] => utility
[patent_app_number] => 16/531698
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531698 | Ultrasound Gel Composition | Aug 4, 2019 | Abandoned |
Array
(
[id] => 15405519
[patent_doc_number] => 20200023081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => SELF-ASSEMBLING CYCLOPEPTIDE-DYE COMPOUNDS, FORMULATIONS THEREOF, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/519101
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519101 | SELF-ASSEMBLING CYCLOPEPTIDE-DYE COMPOUNDS, FORMULATIONS THEREOF, AND USES THEREOF | Jul 22, 2019 | Abandoned |
Array
(
[id] => 17227227
[patent_doc_number] => 20210353783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => IMAGING AGENTS FOR RADIOLABELING EXOGENOUS AND ENDOGENOUS ALBUMIN
[patent_app_type] => utility
[patent_app_number] => 17/262133
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262133 | IMAGING AGENTS FOR RADIOLABELING EXOGENOUS AND ENDOGENOUS ALBUMIN | Jul 15, 2019 | Pending |
Array
(
[id] => 16335644
[patent_doc_number] => 10786582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Gd(III)-dithiolane gold nanoparticle conjugates
[patent_app_type] => utility
[patent_app_number] => 16/504021
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 50
[patent_no_of_words] => 19805
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504021 | Gd(III)-dithiolane gold nanoparticle conjugates | Jul 4, 2019 | Issued |
Array
(
[id] => 17460247
[patent_doc_number] => 20220073552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => REAGENT AND PROCESS FOR THE SITE-SPECIFIC DEOXYFLUORINATION OF PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/257387
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257387
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257387 | REAGENT AND PROCESS FOR THE SITE-SPECIFIC DEOXYFLUORINATION OF PEPTIDES | Jul 2, 2019 | Pending |
Array
(
[id] => 16806205
[patent_doc_number] => 20210128758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
[patent_app_type] => utility
[patent_app_number] => 17/251786
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251786 | Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use | Jun 19, 2019 | Pending |